Back to results
CompletedPhase 2

Bryostatin Treatment of Moderately Severe Alzheimer's Disease

NCT04538066

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Axiom Research

Colton, California, United States

+18 additional locations

View on ClinicalTrials.gov